MedTrace Logo

Eye Surface Properties After Using Dexamethasone Drops With and Without Preservatives in Patients After Cataract Surgery

NCT05753787 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-09-28

No results posted yet for this study

Summary

The goal of this interventional, real world data study is to evaluate the impact of preservatives on the post-cataract ocular surface.

The main question is to learn about an effect of preservatives on the eye surface. The study aims to answer some important questions:

* if the usage of preservatives has an impact on the eye surface healing process after cataract surgery
* if patient comfort and quality of life improve more or more rapidly with preservatives-free eye drops.

Participants will be asked to undergo standard procedure of peri-cataract surgery care and in addition to survey about the ocular surface state.

Researchers will compare group that takes preservatives-free dexamethasone 0.1% with standard dexamethasone 0.01% solution to see if post-surgery eye surface healing properties differ from both groups.

Conditions

  • Cataract
  • Surgical Injury
  • Healing Wound

Interventions

OTHER

preservative-free solution of standard post-cataract eye drops

Usage of preservative-free eye drops in comparison to the standard preserved drops with dexamethasone 0.01%.

Sponsors & Collaborators

  • Wrocław University of Science and Technology

    collaborator OTHER

  • Spektrum Center of Clinical Ophthalmology

    lead OTHER

Principal Investigators

  • Maria Muzyka-Woźniak, PhD · Spektrum Clinic of Ophthalmology

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-31
Completion
2025-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05753787 on ClinicalTrials.gov